EXC
53
-3
HAS
33
3
SCHW
62
-2
DVN
21
3
TXT
55
3
SE
61
-4
NRG
49
-3
BSX
67
-3
PYPL
54
2
CRM
67
2
UPS
60
9
R
71
4
MSFT
50
3
TSCO
49
5
HOG
35
2
XRAY
28
2
PM
62
-2
HON
67
2
LYB
39
2
BK
74
2
EXC
53
-3
HAS
33
3
SCHW
62
-2
DVN
21
3
TXT
55
3
SE
61
-4
NRG
49
-3
BSX
67
-3
PYPL
54
2
CRM
67
2
UPS
60
9
R
71
4
MSFT
50
3
TSCO
49
5
HOG
35
2
XRAY
28
2
PM
62
-2
HON
67
2
LYB
39
2
BK
74
2
Financhill
Back

Catalyst Pharmaceuticals Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
48

CPRX
Catalyst Pharmaceuticals

Last Price:
21.47
Seasonality Move:
4.48%
Sell
33

SRPT
Sarepta Therapeutics

Last Price:
114.28
Seasonality Move:
16.38%
Sell
48
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.48. The Score for CPRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $114.23. The Score for SRPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.48
    The current trend is relatively stagnant and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $114.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 48.92 Sell
Chaikin Money Flow: 621365 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.03 - 22.71) Sell
Bollinger Bands (100): (17.61 - 21.71) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.42 Sell
Relative Strength Index (14 RSI): 44.35 Sell
Chaikin Money Flow: 638386 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.48 - 129.26) Sell
Bollinger Bands (100): (119.5 - 143.18) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.38 Buy
20-day SMA: 22 Sell
50-day SMA: 21.11 Buy
200-day SMA: 17.57 Buy
8-day EMA: 21.5 Sell
20-day EMA: 21.67 Sell
50-day EMA: 21.07 Buy
200-day EMA: 18.25 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.13 Buy
20-day SMA: 118.03 Sell
50-day SMA: 122 Sell
200-day SMA: 130.03 Sell
8-day EMA: 111.53 Buy
20-day EMA: 115.85 Sell
50-day EMA: 121.84 Sell
200-day EMA: 126.04 Sell

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.72 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):